Pancreatic Cancer Research

ResearcherChanghua Christian HospitalNo recent work listed

Chin-Cheng Su

Matched on OpenAlex author ID A5010674323.

Their work

Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.

Pancreatic cancer papers
2 (first author 1, last author 1)
Pancreatic cancer trials
0
Pancreatic cancer grants
0
Collaborators
1
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper

Papers 2

  1. Tanshinone IIA can inhibit MiaPaCa‑2 human pancreatic cancer cells by dual blockade of the Ras/Raf/MEK/ERK and PI3K/AKT/mTOR pathways. First author DOI 10.3892/or.2018.6670↗
  2. Tanshinone IIA increases protein expression levels of PERK, ATF6, IRE1α, CHOP, caspase‑3 and caspase‑12 in pancreatic cancer BxPC‑3 cell‑derived xenograft tumo… Last author DOI 10.3892/mmr.2017.6359↗

Closest collaborators

The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

  1. Tsung-Lang Chiu · 1 shared paper, 2017

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.